Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Jan
3
2023
 Cosmetic Regulatory Reform Finally Becomes Law Mintz
Jan
3
2023
 2022, Who Were You? A Recap of Hot Issues in 2022. Bradley Arant Boult Cummings LLP
Jan
3
2023
 FDA Releases 2022 Edition of the Food Code Keller and Heckman LLP
Jan
3
2023
 A Way Too Early Prediction: Alabama Cannabis 2.0 Bradley Arant Boult Cummings LLP
Dec
31
2022
 China to Remove Infringing Pharmaceuticals from Procurement Platforms Schwegman, Lundberg & Woessner, P.A.
Dec
30
2022
 Potential Litigation Impacts of the Modernization of Cosmetics Regulation Act of 2022 Greenberg Traurig, LLP
Dec
30
2022
 Companies Gear Up For Mass Production of Cultured Meat Womble Bond Dickinson (US) LLP
Dec
30
2022
 New Cosmetic Regulatory Requirements: What Cosmetic Manufacturers Need to Know Greenberg Traurig, LLP
Dec
29
2022
 Mississippi Medical Cannabis, Charles Dickens Style Bradley Arant Boult Cummings LLP
Dec
29
2022
 Welcome (but Last Minute) Relief for Prescription Drug Reporting Originally Due December 27 McDermott Will & Schulte LLP
Dec
29
2022
 Petition Filed to Add Polyoxymethylene to List of Chemical Substances Subject to Superfund Excise Tax Bergeson & Campbell, P.C.
Dec
29
2022
 Doctor-Patient Relationships and Medical Marijuana: Where Are We Now?
Dec
28
2022
 EPA Finds Carbon Tetrachloride, as a Whole Chemical Substance, Poses an Unreasonable Risk to Human Health Bergeson & Campbell, P.C.
Dec
28
2022
 Consolidated Appropriations Act, 2023 Contains Significant Provisions for Cosmetic Products ArentFox Schiff LLP
Dec
28
2022
 RxDC Reporting Relief for Plans, Issuers, and Plan Service Providers Foley & Lardner LLP
Dec
28
2022
 Federal Regulators Offer Employer Health Plans Last-Minute Relief on Prescription Drug Reporting Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Dec
27
2022
 EPA Announces Removal of PFAS Chemicals from Approved Inert Ingredient List for Pesticide Products Bergeson & Campbell, P.C.
Dec
27
2022
 FDA Expands Inspection Guidance to Apply to Device Manufacturers Sheppard, Mullin, Richter & Hampton LLP
Dec
24
2022
 Back to the Drawing Board: CMS Proposes Changing the Overpayment Rule’s “Identified” Definition McDermott Will & Schulte LLP
Dec
24
2022
 The Greatest Gift of All…Tri-Agencies Issue Welcome Relief on Prescription Drug Reporting Proskauer Rose LLP
Dec
23
2022
 OECD Accepting Comment on Draft Study Report on Applicability of the key event based TG 442D for in vitro skin sensitisation testing of nano-materials Bergeson & Campbell, P.C.
Dec
22
2022
 Omnibus Bill for Fiscal Year 2023 (H.R. 2617) – Cosmetics Summary Keller and Heckman LLP
Dec
22
2022
 Consumer Reports Evaluates Heavy Metals in Chocolate Keller and Heckman LLP
Dec
22
2022
 Heinz PFAS Consumer Fraud Lawsuit Continues 2022 Trend CMBG3 Law
Dec
21
2022
 PTO Expands the Scope of the Immunotherapy Pilot Program
Dec
21
2022
 ANSES Applies Methodology to Assess Risks of Nanomaterials in Food to Titanium Dioxide Bergeson & Campbell, P.C.
Dec
21
2022
 FTC Revises Longstanding “Dietary Supplement Guide” to Cover all Health Products Hunton Andrews Kurth
Dec
21
2022
 FDA Issues Final Guidance on GRAS Panel Best Practices Keller and Heckman LLP
Displaying 2997 - 3024 of 12593
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters